Home » Topics » BioWorld Science

BioWorld Science
RSS

Inflazyme/SuperGen future licensing agreement

Aug. 30, 1996

Conjugates for cancer/infectious disease treatment covered by U.S. patent

Aug. 30, 1996

LGD-1069 to enter pivotal U.S. trials

Aug. 30, 1996

AltaRex and Medac finalize Ovarex partnership

Aug. 30, 1996

AG-2034 granted approval for U.S. phase I initiation

Aug. 30, 1996

Phase III trial on Onconase combination initiated

Aug. 30, 1996

New agents for use in transplantation

Aug. 30, 1996

Aviron's intranasal influenza vaccine begins phase III

Aug. 30, 1996

FDA approval requested for thymoglobin manufacturing process, facility

Aug. 30, 1996

Superoxide ion production inhibitors from Sagami

Aug. 30, 1996

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 18, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Dec. 18, 2025.
HIV research is close to a cure but far from ending the pandemic
BioWorld
Advances in antiretroviral therapy (ART) now allow people living with HIV to lead normal lives with undetectable and nontransmissible levels of the virus in their...
Apollo’s APL-4098 shows potent antileukemic effects
BioWorld Science
Apollo Therapeutics Ltd. has developed APL-4098, a small-molecule general control nonderepressible 2 (GCN2) inhibitor for the potential treatment of AML.
ABS-1230 controls seizures in KCNT1-driven severe epilepsy
BioWorld Science
Mutations in the KCNT1 gene produce gain-of-function effects that lead to overactivation of the potassium channel and consequent disruption of normal neuronal...